Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids
Long chain omega-3 polyunsaturated fatty acids (LC n-3 PUFAs) are recommended for management of patients with wide-ranging chronic diseases, including coronary heart disease, rheumatoid arthritis, dementia, and depression. Increased consumption of eicosapentaenoic acid (EPA) and docosahexaenoic acid...
Main Authors: | Fraser D. Russell, Corinna S. Bürgin-Maunder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2012-11-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-3397/10/11/2535 |
Similar Items
-
A fish a day, keeps the cardiologist away! - A review of the effect of omega-3 fatty acids in the cardiovascular system
by: Soumia Peter, et al.
Published: (2013-01-01) -
The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review
by: Jacqueline K. Innes, et al.
Published: (2018-02-01) -
Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
by: Yuji Ueno, et al.
Published: (2019-11-01) -
Embryo-toxicity of docosahexaenoic and eicosapentaenoic acids: In vivo and in silico investigations using the chick embryo model
by: Zohreh Salari, et al.
Published: (2021-04-01) -
The Effect of Eicosapentaenoic Acid Supplementation on Depression Remission: a Double-Blind Randomized Clinical Trial
by: Karamati, et al.
Published: (2011-12-01)